Invention Grant
US09585969B2 Soluble mediator 有权
可溶性介体

Soluble mediator
Abstract:
The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
Public/Granted literature
Information query
Patent Agency Ranking
0/0